![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 4, 2349-2358, January 28, 2000
From the Laboratories of Biochemical and enzymatic characterization of the
novel human subtilase hSKI-1 was carried out in various cell lines.
Within the endoplasmic reticulum of LoVo cells, proSKI-1 is converted to SKI-1 by processing of its prosegment into 26-, 24-, 14-, 10-, and
8-kDa products, some of which remain tightly associated with the
enzyme. N-terminal sequencing and mass spectrometric analysis were used
to map the cleavage sites of the most abundant fragments, which were
confirmed by synthetic peptide processing. To characterize its in
vitro enzymatic properties, we generated a secreted form of
SKI-1. Our data demonstrate that SKI-1 is a
Ca2+-dependent proteinase exhibiting optimal
cleavage at pH 6.5. We present evidence that SKI-1 processes peptides
mimicking the cleavage sites of the SKI-1 prosegment, pro-brain-derived
neurotrophic factor, and the sterol regulatory element-binding protein
SREBP-2. Among the candidate peptides encompassing sections of the
SKI-1 prosegment, the RSLK137- and
RRLL186-containing peptides were
best cleaved by this enzyme. Mutagenesis of the latter peptide allowed
us to develop an efficiently processed SKI-1 substrate and to assess
the importance of several P and P' residues. Finally, we demonstrate
that, in vitro, recombinant prosegments of SKI-1 inhibit
its activity with apparent inhibitor constants of 100-200
nM.
Biosynthesis and Enzymatic Characterization of Human SKI-1/S1P
and the Processing of Its Inhibitory Prosegment*
§,
,
,
,
, and

Biochemical and
¶ Molecular Neuroendocrinology and ** Structure and Metabolism of
Neuropeptides, Protein Engineering Network of Centres of Excellence,
Clinical Research Institute of Montreal, University of Montreal,
Montreal, Quebec H2W 1R7 and the
Protein Chemistry Center, Loeb
Health Research Institute at the Ottawa Hospital and University of
Ottawa, Ottawa, Ontario K1Y 4K9, Canada
*
This work was supported in part by Medical Research Council
(MRC) Group Grant MGC-11474 (to N. G. S. and M. C.), by
MRC Operating Grants MT-NGS (to N. G. S.) and MT-14766 (to
C. L.), and by the Government of Canada's Network of Centers of
Excellence program supported by the MRC and National Sciences and
Engineering Research Council of Canada through Protein Engineering
Network of Centers of Excellence.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.

To whom correspondence should be addressed: Clinical Research
Inst. of Montreal, 110 Pine Ave. W., Montreal, Quebec H2W 1R7, Canada.
Tel.: 514-987-5609; Fax: 514-987-5542; E-mail:
seidahn@ircm.qc.ca.
This article has been cited by other articles:
![]() |
J. L. Hawkins, M. D. Robbins, L. C. Warren, D. Xia, S. F. Petras, J. J. Valentine, A. H. Varghese, I.-K. Wang, T. A. Subashi, L. D. Shelly, et al. Pharmacologic Inhibition of Site 1 Protease Activity Inhibits Sterol Regulatory Element-Binding Protein Processing and Reduces Lipogenic Enzyme Gene Expression and Lipid Synthesis in Cultured Cells and Experimental Animals J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 801 - 808. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pullikotil, S. Benjannet, J. Mayne, and N. G. Seidah The Proprotein Convertase SKI-1/S1P: ALTERNATE TRANSLATION AND SUBCELLULAR LOCALIZATION J. Biol. Chem., September 14, 2007; 282(37): 27402 - 27413. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pasquato, P. Pullikotil, M.-C. Asselin, M. Vacatello, L. Paolillo, F. Ghezzo, F. Basso, C. Di Bello, M. Dettin, and N. G. Seidah The Proprotein Convertase SKI-1/S1P: IN VITRO ANALYSIS OF LASSA VIRUS GLYCOPROTEIN-DERIVED SUBSTRATES AND EX VIVO VALIDATION OF IRREVERSIBLE PEPTIDE INHIBITORS J. Biol. Chem., August 18, 2006; 281(33): 23471 - 23481. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Stirling and P. O'Hare CREB4, a Transmembrane bZip Transcription Factor and Potential New Substrate for Regulation and Cleavage by S1P Mol. Biol. Cell, January 1, 2006; 17(1): 413 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lopez de Cicco, D. E. Bassi, S. Zucker, N. G. Seidah, and A. J.P. Klein-Szanto Human Carcinoma Cell Growth and Invasiveness Is Impaired by the Propeptide of the Ubiquitous Proprotein Convertase Furin Cancer Res., May 15, 2005; 65(10): 4162 - 4171. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Abboud-Jarrous, Z. Rangini-Guetta, H. Aingorn, R. Atzmon, S. Elgavish, T. Peretz, and I. Vlodavsky Site-directed Mutagenesis, Proteolytic Cleavage, and Activation of Human Proheparanase J. Biol. Chem., April 8, 2005; 280(14): 13568 - 13575. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pullikotil, M. Vincent, S. T. Nichol, and N. G. Seidah Development of Protein-based Inhibitors of the Proprotein of Convertase SKI-1/S1P: PROCESSING OF SREBP-2, ATF6, AND A VIRAL GLYCOPROTEIN J. Biol. Chem., April 23, 2004; 279(17): 17338 - 17347. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Vincent, A. J. Sanchez, B. R. Erickson, A. Basak, M. Chretien, N. G. Seidah, and S. T. Nichol Crimean-Congo Hemorrhagic Fever Virus Glycoprotein Proteolytic Processing by Subtilase SKI-1 J. Virol., August 15, 2003; 77(16): 8640 - 8649. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okada, K. Haze, S. Nadanaka, H. Yoshida, N. G. Seidah, Y. Hirano, R. Sato, M. Negishi, and K. Mori A Serine Protease Inhibitor Prevents Endoplasmic Reticulum Stress-induced Cleavage but Not Transport of the Membrane-bound Transcription Factor ATF6 J. Biol. Chem., August 15, 2003; 278(33): 31024 - 31032. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Beyer, D. Popplau, W. Garten, D. von Laer, and O. Lenz Endoproteolytic Processing of the Lymphocytic Choriomeningitis Virus Glycoprotein by the Subtilase SKI-1/S1P J. Virol., March 1, 2003; 77(5): 2866 - 2872. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Seidah, S. Benjannet, L. Wickham, J. Marcinkiewicz, S. B. Jasmin, S. Stifani, A. Basak, A. Prat, and M. Chretien The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation PNAS, February 4, 2003; 100(3): 928 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nour, A. Basak, M. Chretien, and N. G. Seidah Structure-Function Analysis of the Prosegment of the Proprotein Convertase PC5A J. Biol. Chem., January 24, 2003; 278(5): 2886 - 2895. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Sanchez, M. J. Vincent, and S. T. Nichol Characterization of the Glycoproteins of Crimean-Congo Hemorrhagic Fever Virus J. Virol., June 14, 2002; 76(14): 7263 - 7275. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Elagoz, S. Benjannet, A. Mammarbassi, L. Wickham, and N. G. Seidah Biosynthesis and Cellular Trafficking of the Convertase SKI-1/S1P. ECTODOMAIN SHEDDING REQUIRES SKI-1 ACTIVITY J. Biol. Chem., March 22, 2002; 277(13): 11265 - 11275. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Lenz, J. ter Meulen, H.-D. Klenk, N. G. Seidah, and W. Garten The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P PNAS, October 12, 2001; (2001) 221447598. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Benjannet, A. Elagoz, L. Wickham, M. Mamarbachi, J. S. Munzer, A. Basak, C. Lazure, J. A. Cromlish, S. Sisodia, F. Checler, et al. Post-translational Processing of beta -Secretase (beta -Amyloid-converting Enzyme) and Its Ectodomain Shedding. THE PRO- AND TRANSMEMBRANE/CYTOSOLIC DOMAINS AFFECT ITS CELLULAR ACTIVITY AND AMYLOID-beta PRODUCTION J. Biol. Chem., March 30, 2001; 276(14): 10879 - 10887. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Lenz, J. ter Meulen, H.-D. Klenk, N. G. Seidah, and W. Garten The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P PNAS, October 23, 2001; 98(22): 12701 - 12705. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |